Literature DB >> 10098836

Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter.

K Krohn1, I Rozovsky, P Wals, B Teter, C P Anderson, C E Finch.   

Abstract

Elevated expression of glial fibrillary acidic protein (GFAP) is associated with astrocyte activation during responses to injury in the CNS. Because transforming growth factor-beta1 (TGF-beta1) and interleukin-1beta (IL-1beta) are released during neural responses to injury and because these cytokines also modulate GFAP mRNA levels, it is of interest to define their role in GFAP transcription. The increases of GFAP mRNA in response to TGF-beta1 and decreases in response to IL-1beta were shown to be transcriptionally mediated in rat astrocytes transfected with a luciferase-reporter construct containing 1.9 kb of 5'-upstream rat genomic DNA. Constructs containing sequential deletions of the rat GFAP 5'-upstream promoter identified a short region proximal to the transcription start (-106 to -53 bp) that provides full responses to TGF-beta1 and IL-1beta. This region contains an unusual sequence motif with overlapping nuclear factor-1 (NF-1)- and nuclear factor-kappaB (NF-kappaB)-like binding sites and homology to known TGF-beta response elements. Mutagenesis (3-bp exchanges) in -70 to -68 bp blocked the induction of GFAP by TGF-beta1 and the repression by IL-1beta. Gel shift experiments showed that the DNA segment -85 to -63 bp was bound by a factor(s) in nuclear extracts from astrocytes. The concentrations of these DNA binding factors were increased by treatment of astrocytes with TGF-beta1 and decreased by IL-1beta. Binding of these nuclear factors was blocked by mutation of -70 to -68 bp. Despite homology to NF-1 or NF-kappaB binding sites in the GFAP promoter at segment -79 to -67 bp, anti-NF-kappaB or anti-NF-1 antibodies did not further retard the gel shift of the nuclear factors/DNA complex. Moreover, astrocytic nuclear proteins do not compete for the specific binding to NF-1 consensus sequence. Thus, nuclear factors from astrocytes that bind to the -85- to -63-bp promoter segment might be only distantly related to NF-1 or NF-kappaB. These findings are pertinent to the use of GFAP promoter constructs in transgenic animals, because cisacting elements in the GFAP promoter are sensitive to cytokines that may be elaborated in response to expression of transgene products.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098836     DOI: 10.1046/j.1471-4159.1999.721353.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

1.  Drug screening to identify suppressors of GFAP expression.

Authors:  Woosung Cho; Michael Brenner; Noel Peters; Albee Messing
Journal:  Hum Mol Genet       Date:  2010-06-10       Impact factor: 6.150

2.  Involvement of nuclear factor-1 (NF1) binding motif in the regucalcin gene expression of rat kidney cortex: the expression is suppressed by cisplatin administration.

Authors:  H Misawa; M Yamaguchi
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport.

Authors:  Charles R Buck; Michael J Jurynec; Deepak K Gupta; Alick K T Law; Johannes Bilger; Douglas C Wallace; Robert J McKeon
Journal:  Exp Neurol       Date:  2003-06       Impact factor: 5.330

4.  The unique transcriptional activation domain of nuclear factor-I-X3 is critical to specifically induce marker gene expression in astrocytes.

Authors:  Sandeep K Singh; Katarzyna M Wilczynska; Adrian Grzybowski; Jessie Yester; Bahiya Osrah; Lauren Bryan; Sarah Wright; Irene Griswold-Prenner; Tomasz Kordula
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

5.  Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression.

Authors:  Federico Herrera; Qi Chen; David Schubert
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

6.  GFAP promoter directs lacZ expression specifically in a rat hepatic stellate cell line.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Chun-Yan Zhang; Lang Zhuo
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

Review 7.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 8.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

9.  Pioglitazone ameliorates retinal ischemia/reperfusion injury via suppressing NLRP3 inflammasome activities.

Authors:  Yue-Lu Zhang; Ruo-Bing Wang; Wei-Yi Li; Fang-Zhou Xia; Lin Liu
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

Review 10.  PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.

Authors:  Mario Vallejo
Journal:  Mol Neurobiol       Date:  2009-02-24       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.